Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets
- 1 January 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 412 (1) , 45-50
- https://doi.org/10.1016/s0014-2999(00)00933-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidationNeuropharmacology, 1999
- Understanding cell death in parkinson's diseaseAnnals of Neurology, 1998
- GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian miceNeuroReport, 1998
- Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 miceNeuroscience Letters, 1998
- The role of neuronal growth factors in neurodegenerative disorders of the human brainBrain Research Reviews, 1998
- GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitroCell and tissue research, 1997
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neuronsBrain Research, 1995
- Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brainNature, 1995
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993